Featured Research

from universities, journals, and other organizations

Novel Treatment Reduces Swollen Livers

Date:
August 18, 2009
Source:
Radboud University Nijmegen Medical Centre
Summary:
A novel treatment strategy for patients with many cysts in their liver led to a surprising result. A six month treatment with a synthetic gastrointestinal hormone lanreotide significantly decreased swollen cystic livers by approximately five percent, compared to a 'wait and see' policy.

A novel treatment strategy for patients with many cysts in their liver led to a surprising result, reported in the online version of Gastroenterology by researchers from Radboud University Nijmegen Medical Centre, The Netherlands. A six month treatment with a synthetic gastrointestinal hormone lanreotide significantly decreased swollen cystic livers by approximately five percent, compared to a ‘wait and see’ policy.

At least five percent of the population has one or two cysts in the liver. Cysts are fluid-filled cavities. There are also many patients who have numerous cysts, which then is termed a polycystic liver. These cysts cause the liver to grow to four to six times its normal size. Until recently, surgery was the only possible treatment for these patients, but this approach leads to many complications, and the outcome is not always successful. Ultimately, these patients need a liver transplantation, but in view of the limited availability of organs, only few are actually transplanted.

Hepatologist Prof. Drenth, from Radboud University Nijmegen Medical Centre, commented: "In Nijmegen, we had experience with the administration of synthetic gastrointestinal hormones in two polycystic liver patients. This treatment resulted in significantly smaller liver cysts. This stimulated us to proceed to a randomized clinical trial in 54 polycystic liver patients from Nijmegen (The Netherlands) and Leuven (Belgium). Computer tomography indicated that the size of the average liver was 4.6 liters, at least three times the normal size. Twenty-seven patients received a monthly injection of lanreotide, and results were compared with 27 patients who received a placebo injection. After six months with lanreotide, the liver size was reduced by 2.9 percent, while that of the placebo group increased by 1.6 percent. Lanreotide worked best for patients with the largest livers."

This novel approach allows physicians to avoid the prospect of surgery. In the Netherlands there is an estimated group of 17,000 patients with polycystic livers, three quarters will face surgery because of their disease.


Story Source:

The above story is based on materials provided by Radboud University Nijmegen Medical Centre. Note: Materials may be edited for content and length.


Journal Reference:

  1. van Keimpema L, Nevens F, Vanslembrouck R, van Oijen M.G., Hoffmann A.L., Dekker H.M., de Man R.A., Drenth J.P. Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial. Gastroenterology, 2009; DOI: 10.1053/j.gastro.2009.07.052

Cite This Page:

Radboud University Nijmegen Medical Centre. "Novel Treatment Reduces Swollen Livers." ScienceDaily. ScienceDaily, 18 August 2009. <www.sciencedaily.com/releases/2009/08/090814101835.htm>.
Radboud University Nijmegen Medical Centre. (2009, August 18). Novel Treatment Reduces Swollen Livers. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2009/08/090814101835.htm
Radboud University Nijmegen Medical Centre. "Novel Treatment Reduces Swollen Livers." ScienceDaily. www.sciencedaily.com/releases/2009/08/090814101835.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins